There is no report of additional type of bulk bone grafting (Ad-BG) method with impaction morselized bone graft for reconstruction of shallow dysplastic hip in total hip arthroplasty. The purpose of this study was to define the shallow acetabulum and to evaluate the clinical and radiographic results of primary total hip arthroplasty (THA) with Ad-BG method. With modification of Crowe's classification, shallow dysplasia was defined and classified BACKGROUND
MATERIALS and METHODS
Although most radiographs used for polyethylene wear measurements have been taken with the patient in the supine position in order to assess penetration by the femoral head into the acetabular polyethylene socket, we have questioned the effect of weight-bearing on the position of the head within the socket. The current study aimed to determine the effect of weight bearing, i.e. standing on the two-dimensional radiographic position of the femoral head within the socket. A total of three hundred and fifty patients (three hundred and eighty three hips) who had had a total hip arthroplasty had digital radiographs made a set of anteroposterior radiographs for each patient: one radiograph was made with the patient supine and one was made with the patient standing in full weight bearing on the replaced hip. The patients were divided into the following two groups: 1) seventy-five patients (eighty-three hips) with conventional polyethylene (CON) (group-1); 2) two hundred and seventy-five patients (three hundred hips) with highly cross-linked polyethylene (XPL) (group-2). The set of radiograph was taken at three weeks postoperatively and at the time of semiannual follow-up. The average ceramic femoral head penetration was measured with radiographs taken in the standing or supine position at the final follow-up and compared with those of three weeks postoperatively. A single researcher with use of a computerized measurement system performed all measurements on the radiographs of the two-dimensional position of the head. Follow-up period were 13.5 ± 1.0 (range. 11.0–15.5) years in group-1 and 7.6 ± 2.1 (range. 5.0–12.6) years in group-2.BACKGROUND:
PATIENTS AND METHODS: